Wegovy and Ozempic have made headlines, but a new wave of more effective drugs like Mounjaro have the potential to end obesity altogether. How will they work and are they safe?
There are TikTok hashtags with millions of followers, endless column inches over celebrities’ waistlines and streams of media coverage when trial results come out. It is rare that a new medicine gets so much attention. Then again, it is even rarer that a licensed drug causes safe and rapid weight loss with minimal effort.
A year ago, most people hadn’t heard of semaglutide, a drug developed to treat type 2 diabetes around a decade ago under the brand name Ozempic. Then, in 2021, it was approved in the US as a weight-loss aid under the name Wegovy. The medicine can cause people to lose a whopping 15 per cent of their body weight.
The impact of this new class of medicines could be unprecedented – potentially bringing to an end the world’s growing obesity epidemic. “I don’t think it’s fully sunk in yet,” saysat Duke University in North Carolina, who investigates how these drugs affect the body. For one thing, Wegovy was just the start. The next generation of these drugs is in development and will be cheaper, easier to use and, crucially, even more potent. What’s more, emerging evidence suggests Wegovy and its ilk work better when given at a younger age, so doctors are exploring their use in teenagers and young children. This raises the prospect of switching from obesity treatment to prevention.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
European drugs regulator to review Wegovy, Ozempic following reports of suicidal thoughtsDanish firm Novo Nordisk says “patient safety is a top priority” following reports.
Leer más »
Popular weight loss drug gets new warningWegovy and Ozempic are brand names for a drug called semaglutide.
Leer más »
EU medicines regulator is reviewing weight-loss drugs Ozempic and Wegovy for risk of suicidal thoughts and self-harmThe European Medicines Agency said Tuesday it’s reviewing data on the risk of suicidal thoughts and self-harm stemming from the use of the new medicines...
Leer más »
A One-Time Shot for Type 2 Diabetes? A Biotech Company Is On ItFractyl Health is developing a gene therapy alternative to drugs like Ozempic and Wegovy to control blood sugar and body weight without repeated injections.
Leer más »
EU probes Ozempic, weight-loss drug Saxenda after reports of suicidal thoughtsThe European Medicines Agency (EMA) is investigating Novo Nordisk's diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland's health regulator flagged three cases of patients thinking about suicide or self-harm.
Leer más »
EU Investigates Ozempic Maker After Reports Of Suicidal ThoughtsThe Danish pharma giant finds itself under scrutiny once again- this time, from European regulators.
Leer más »